Table 3.
Day | Group 1: negative control | Group 2: treated (Effitix®) | ||||
---|---|---|---|---|---|---|
Arithmetic mean | Standard deviation | Geometric mean | Arithmetic mean | Standard deviation | Geometric mean | |
+2 | 21.3 | 3.1 | 21.1 | 0.5 (1) | 0.8 | 0.4 |
+9 | 17.5 | 3.4 | 17.2 | 0.0 (1) | 0.0 | 0.0 |
+16 | 16.5 | 3.8 | 16.2 | 0.0 (1) | 0.0 | 0.0 |
+23 | 19.7 | 3.1 | 19.5 | 0.0 (1) | 0.0 | 0.0 |
+30 | 20.8 | 3.8 | 20.5 | 1.5 (1) | 2.8 | 0.7 |
+37 | 21.2 | 2.1 | 21.1 | 1.0 (1) | 0.9 | 0.8 |
1: Group 2 differed statistically significantly (p < 0.05) from the untreated control Group 1 on all assessment days.